Pain, 2021 Placebo effects have traditionally involved concealment or deception. However, recent evidence suggests that placebo effects can also be elicited when prescribed transparently as "open-label placebos" (OLP), and that the pairing of an unconditioned ...
K. Flowers +9 more
semanticscholar +1 more source
Effects of study design and allocation on participant behaviour-ESDA: study protocol for a randomized controlled trial [PDF]
, 2011 Background: What study participants think about the nature of a study has been hypothesised to affect subsequent behaviour and to potentially bias study findings.
AJ de Craen +24 more
core +5 more sources
Design, formulation and sensory evaluation of a polyphenol-rich food placebo: an example of aronia juice for food intervention studies [PDF]
, 2017 Products suitable for use as controls in food interventions designed to demonstrate the role of minor components are largely lacking. In the present study, we aimed to develop a formulation to be used as a placebo in a clinical trial designed to assess ...
Aleksandra Konic Ristic +16 more
core +1 more source
Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis [PDF]
, 2015 Placebos have long provided a robust control for evaluating active pharmacological preparations, but frequently demonstrate a variable therapeutic effect when delivered in double-blinded placebo-controlled trials.
Charlesworth, JE +5 more
core +2 more sources
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. [PDF]
, 2015 OBJECTIVE: The authors examined research on effects, costs, and patient and caregiver views of pharmacological management strategies for Lewy body dementia.
Cambridge, Victoria +9 more
core +2 more sources
Alternative psychotherapies: Conceptual elucidation and epidemiological framework [PDF]
, 2020 This article elucidates and defines alternative psychotherapies, as well as describes the variables that explain why some professional psychologists are prone to endorse these practices.
Adrián-Ventura, Jesús, Fasce, Angelo
core +1 more source
General Practitioners Attitudes towards Open-Label Placebos in Australia [PDF]
, 2018 This item is only available electronically.Objective: Multiple studies have found between 18-70% of medical professionals prescribe placebos, with general practitioners’ (GPs) reportedly being the highest prescribers.
Matthews, Kaitlin
core
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Placebo effects in health and disease : how expectations shape treatment outcomes [PDF]
, 2016 The context in which a medical treatment is administrated influences treatment outcomes. As of today, the health care system has little knowledge about the non-specific components that contribute to the positive effect of a given therapy, often referred ...
Rosén, Annelie
core +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source